JPMorgan issues 2.10× Accelerated Barrier Notes vs. SPXFP
JPMorgan Chase Financial Company LLC is offering uncapped Accelerated Barrier Notes linked to the S&P 500® Futures Excess Return Index with a stated Upside Leverage Factor of at least 2.10.
Rhea-AI Filing Summary
JPMorgan Chase Financial Company LLC is offering uncapped Accelerated Barrier Notes linked to the S&P 500® Futures Excess Return Index with a stated Upside Leverage Factor of at least 2.10. The notes have a Barrier Amount equal to 70.00% of the Initial Value and a stated maturity of July 3, 2031. Payment at maturity: if the Index finishes above the Initial Value you receive $1,000 plus the Index Return times the Upside Leverage Factor; if the Final Value is between the Initial Value and the Barrier you receive principal; if the Final Value is below the Barrier you suffer proportional principal loss.
The notes are unsecured obligations of JPMorgan Financial, fully and unconditionally guaranteed by JPMorgan Chase & Co.. Expected pricing is on or about June 30, 2026 with settlement on or about July 6, 2026. The estimated value at pricing is shown as $958.10 per $1,000 note and will not be less than $900.00 per $1,000 note when set. Minimum denomination is $1,000. The notes do not pay interest and are not FDIC insured.
Positive
- None.
Negative
- None.
Insights
Product mixes leveraged upside with a deep downside barrier; payoff depends on index futures excess-return dynamics.
The structure offers at least a 2.10 upside multiple of positive Index returns and a 70.00% barrier that preserves principal only if the Final Value stays at or above that level. The payoff uses the excess-return futures index, not the cash S&P 500 index, so financing costs and roll effects materially drive long-term performance.
Secondary market liquidity is limited (unlisted) and the estimated value at issue ($958.10) is below the issue price ($1,000) because fees and hedging costs are included. Subsequent pricing and hedging outcomes will affect any repurchase offers; timing and prices are specified in the pricing supplement.
Tax treatment is expected to be as an "open transaction" but remains subject to counsel confirmation and regulatory risk.
The pricing supplement states the issuer will seek an opinion treating the notes as open transactions (non-debt) for U.S. federal income tax purposes, which could result in long-term capital gain treatment for holders who hold over one year. That treatment is not guaranteed and the IRS or courts could reach a different conclusion.
Section 871(m) analysis is addressed: the issuer expects it not to apply to these notes under stated determinations, but the issuer notes the IRS could disagree. Purchasers should consider potential withholding or recharacterization risk tied to future guidance.
Key Figures
Key Terms
Upside Leverage Factor financial
Barrier Amount financial
Negative roll return market
Open transactions regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What are the key payout mechanics for JPM structured notes linked to SPXFP?
When will the notes price and settle for JPMorgan Chase Financial notes (CUSIP 46661ALM0)?
What is the estimated value and how does it compare to the issue price?
How does the Barrier Amount affect principal protection on these notes?
Are these notes covered by the Commodity Exchange Act or FDIC insurance?
AI-generated analysis. How Rhea-AI works. Not financial advice.